Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (77)

2024

  1. Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses

    OncoImmunology, Vol. 13, Núm. 1

  2. Glial cell activation precedes neurodegeneration in the cerebellar cortex of the YG8–800 murine model of Friedreich ataxia

    Neurobiology of Disease, Vol. 200

  3. Kdm1a safeguards the topological boundaries of PRC2-repressed genes and prevents aging-related euchromatinization in neurons

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  2. Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment

    Biomolecules, Vol. 13, Núm. 7

  3. Personalized diagnostic approach and indirect quantification of extravasation in human anaphylaxis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 202-213

  4. Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis

    Biomedicine and Pharmacotherapy, Vol. 150

  2. Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target

    Diabetes, Vol. 71, Núm. 3, pp. 497-510

  3. Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

    Oncoimmunology, Vol. 11, Núm. 1, pp. 2034355

2021

  1. Antibody-based immunotoxins for colorectal cancer therapy

    Biomedicines, Vol. 9, Núm. 11

2020

  1. Analysis of putative epigenetic regulatory elements in the FXN genomic locus

    International Journal of Molecular Sciences, Vol. 21, Núm. 10

  2. Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma

    Exercise immunology review, Vol. 26, pp. 100-115

  3. Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR

    Frontiers in Immunology, Vol. 11

  4. Enhanced Production of Herpes Simplex Virus 1 Amplicon Vectors by Gene Modification and Optimization of Packaging Cell Growth Medium

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 491-496

2019

  1. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  2. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma

    Human Molecular Genetics, Vol. 27, Núm. 17, pp. 3046-3059

2016

  1. Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains

    Scientific Reports, Vol. 6

  2. Toward liquid biopsy: Determination of the humoral immune response in cancer patients using halotag fusion protein-modified electrochemical bioplatforms

    Analytical Chemistry, Vol. 88, Núm. 24, pp. 12339-12345